Rootsaert Rodney Gerard 4
4 · VOLITIONRX LTD · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
VolitionRx (VNRX) Sec. Rodney Rootsaert Cancels 3,321 Shares
What Happened
- Rodney Gerard Rootsaert, Secretary of VolitionRx Ltd. (VNRX), had 3,321 shares of common stock cancelled by the company on 2026-03-01 to satisfy tax withholding related to the settlement of restricted stock units (RSUs). The withheld shares were valued at $0.21 each, totaling approximately $707.
- The filing notes 7,908 RSUs were settled in lieu of cash compensation; after withholding 3,321 shares for taxes, roughly 4,587 net shares were implied to be delivered to the reporting person.
Key Details
- Transaction date: 2026-03-01; Filing date: 2026-03-03 (appears timely).
- Reported disposition: 3,321 shares withheld/cancelled at $0.21 per share; aggregate value ≈ $707.
- Footnote: The withheld shares were retained by VolitionRx to satisfy tax withholding on RSU settlement (no open-market sale occurred).
- Ownership note: Some common stock holdings are held directly by Concord International, Inc.; Rootsaert is a controlling director of Concord and shares voting/dispositive control over those shares.
- Shares owned after the transaction: Not specified in the Form 4.
Context
- This is a tax-withholding (F-code) transaction tied to RSU settlement, not a market sale—common when companies issue equity in lieu of cash and withhold shares to cover taxes.
- Such withholding transactions are routine administrative matters and do not by themselves indicate a buy or sell signal by the insider.
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Rootsaert Rodney Gerard
Secretary
Transactions
- Tax Payment
Common Stock
[F1]2026-03-01$0.21/sh−3,321$707→ 277,941 total
Holdings
- 1,007,718(indirect: By Concord International, Inc.)
Common Stock
[F2]
Footnotes (2)
- [F1]Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 7,908 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.
- [F2]The shares of common stock are held directly by Concord International, Inc. The reporting person is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.
Signature
/s/ Rodney Gerard Rootsaert|2026-03-03